查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1943298

生物醫用紡織品市場－全球產業規模、佔有率、趨勢、機會及預測（按纖維類型、織物類型、應用、地區和競爭格局分類，2021-2031年）

Biomedical Textiles Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Fibre Type, By Fabric Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生物醫學紡織品市場預計將從 2025 年的 158.3 億美元成長到 2031 年的 229.8 億美元，複合年成長率為 6.41%。

這些特殊材料，包括工程纖維結構，對於各種生物和醫學應用至關重要，其應用範圍涵蓋血管移植物和縫線等植入式解決方案，以及防護衣和手術敷料等非植入式產品。市場的主要促進因素是醫療保健需求的結構性變化，特別是人口快速老化和慢性病發病率上升，這些因素共同導致手術干預次數增加，對長期傷口管理的需求也隨之成長，從而對感染控制和卓越的生物相容性產生了持續的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 158.3億美元
市場規模：2031年 229.8億美元
複合年成長率：2026-2031年 6.41%
成長最快的細分市場 不可生物分解纖維
最大的市場 亞太地區

然而，由於醫療設備法規環境日益嚴格，市場面臨巨大的挑戰。製造商必須應對複雜的合規要求，例如歐洲醫療設備法規 (MDR) 和美國食品藥物管理局 (FDA) 的標準，這些要求需要進行大量的臨床試驗，延長產品核可時間，從而增加研發成本和准入門檻。儘管面臨這些商業挑戰，該行業仍然是擴張的重點。據先進紡織品協會 (Advanced Textiles Association) 稱，到 2024 年，24% 的受訪業內人士認為醫療市場是一個關鍵的成長領域，這凸顯了該市場在監管限制下的巨大潛力。

市場促進因素

文明病疾病和慢性病的日益增多，從根本上改變了生物醫用紡織品的需求，尤其是在長期照護和傷口管理領域。肥胖、靜脈功能不全和糖尿病等疾病需要持續使用特殊紡織材料，例如壓力衣和抗菌敷料，以治療複雜的潰瘍並減少繼發性感染。這些不斷變化的患者需求正在推動專注於先進治療解決方案的公司實現收入成長。例如，康維特集團（Convatec Group Plc）於2024年11月發布的《截至2024年10月31日的10個月財務趨勢》報告顯示，集團有機銷售額實現了7.7%的穩健成長。史密斯醫療（Smith+Nephew）於2024年10月發布的《2024年第三季財務業績》也指出，其先進傷口管理部門的收入按報告數據計算成長了6.5%，反映了全球對先進創傷護理產品日益成長的需求。

同時，全球微創手術和治療數量的不斷成長是生物醫用紡織品行業的關鍵驅動力。新興市場醫療基礎設施的完善以及全球人口老化導致醫療干預頻率的增加，正推動植入式紡織產品（如血管移植物和疝氣修補網片）和非植入式一次性產品（如手術罩衣和手術鋪巾）的使用量相應成長。領先醫療科技公司的財務表現也印證了這一上升趨勢。根據Medtronic於2024年5月發布的2024會計年度收益報告，其醫療外科產品組合的全球銷售額成長了5.4%，這主要得益於外科解決方案領域的強勁成長。這凸顯了生物相容性織物在繁忙的醫院環境中維持感染控制和支持手術流程的重要作用。

市場挑戰

醫療設備嚴格的監管架構對全球生物醫用紡織品市場的擴張構成重大障礙。製造商被迫應對複雜的合規要求，包括美國食品藥物管理局 (FDA) 的標準和歐盟醫療設備法規 (MDR)，這顯著延長了產品核可時間並增加了研發成本。這些法規要求提供大量的臨床數據和持續的上市後監測，迫使企業將大量資金和人力資源從研發轉移到合規方面。這減緩了創新步伐，並延緩了植入式醫療器材和先進創傷護理所需的先進紡織醫療解決方案的普及應用。

這種營運壓力直接影響企業的全球競爭力和市場擴大策略。企業越來越不願意在合規要求繁瑣的地區推出新產品，而是傾向於選擇法規環境可預測的市場，或選擇停止生產那些不再獲利的傳統紡織品。根據歐洲醫療技術展（MedTech Europe）預測，到2024年，這些複雜因素導致主要醫療設備製造商選擇歐盟作為其首發產品的首選地區的比例下降了33%。這表明，合規壁壘會增加財務風險，並阻礙新型生物醫學紡織技術在關鍵地區的商業化。

市場趨勢

智慧紡織品嵌入生物感測器的興起正在革新市場，使其價值從被動材料轉變為主動數據生成診斷設備。與傳統服裝或繃帶不同，這些電子紡織品利用奈米技術實現遠端患者監護，無需侵入性設備即可即時追蹤心臟活動和血壓等生命徵象。這項技術的融合透過實現個人化護理路徑和早期療育，支持更廣泛的數位健康生態系統。作為這一進展的標誌，Nanowear 於 2024 年 1 月發布新聞稿，題為“人工智慧驅動的連續血壓監測和高血壓診斷管理系統獲得 FDA 510(k) 許可”，宣布其基於紡織品的穿戴式平台已獲得 FDA 510(k)核准，這標誌著醫用級紡織感測器商業化進程中的重要一步。

同時，該產業正經歷著向環境永續生產技術的結構性轉變，以減少合成纖維和一次性醫療耗材對環境的影響。為了在遵守嚴格的生物相容性標準的同時減少碳排放，製造商正擴大用可生物分解、生物基或回收材料取代石油化學衍生的聚合物。這一趨勢既是競爭優勢，也是監管要求，推動整個供應鏈的營運調整。根據Ahlstrom於2024年3月發布的《2023年永續發展報告》，該公司計劃將其每噸產品的碳排放減少7%，這表明特種材料領域的主要企業正在為綠色製造做出切實努力。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球生物醫用紡織品市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依纖維類型（不可生物分解纖維、可生物分解纖維）
    • 依布料類型（不織布、織布、其他）
    • 依應用方式（非植入式、外科縫合線、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美生物醫用紡織品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章 歐洲生物醫用紡織品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太生物醫用紡織品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲生物醫用紡織品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲生物醫用紡織品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球生物醫用紡織品市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Swicofil AG
  • DSM BV
  • Cortland Biomedical
  • Poly-Med Incorporated
  • Bally Ribbon Mills, Inc.
  • Atex Technologies Inc.
  • Medline Industries Inc.
  • B. Braun Melsungen AG
  • Integra Lifesciences Corporation
  • Elkem ASA

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 2667

The Global Biomedical Textiles Market is projected to expand from USD 15.83 Billion in 2025 to USD 22.98 Billion by 2031, registering a CAGR of 6.41%. These specialized materials, which encompass engineered fibrous structures, are essential for various biological and medical uses, ranging from implantable solutions such as vascular grafts and sutures to non-implantable items like protective apparel and surgical dressings. The market is primarily propelled by structural shifts in healthcare demand, specifically the rapidly aging global population and the increasing incidence of chronic diseases, which collectively drive the volume of surgical interventions and the necessity for long-term wound management, creating a persistent need for infection control and superior biocompatibility.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 15.83 Billion
Market Size 2031USD 22.98 Billion
CAGR 2026-20316.41%
Fastest Growing SegmentNon-Biodegradable Fibre
Largest MarketAsia Pacific

However, the market faces significant headwinds due to an increasingly rigorous regulatory environment for medical devices. Manufacturers must contend with complex compliance requirements, including the European Medical Device Regulation (MDR) and FDA standards, which demand extensive clinical trials and extend the time required for product approval, thereby elevating development costs and entry barriers. Despite these operational difficulties, the sector remains a focal point for expansion; according to the Advanced Textiles Association, in 2024, 24% of surveyed industry professionals pinpointed the medical market as a primary growth sector, underscoring its potential even amidst these regulatory constraints.

Market Driver

The increasing prevalence of lifestyle-related disorders and chronic diseases is fundamentally altering the demand landscape for biomedical textiles, especially within long-term care and wound management sectors. Conditions such as obesity, venous insufficiency, and diabetes require the consistent application of specialized fibrous materials, such as compression garments and antimicrobial dressings, to treat complex ulcers and mitigate secondary infections. This shift in patient requirements is fueling revenue growth for companies dedicated to advanced therapeutic solutions; for instance, according to Convatec Group Plc, November 2024, in the 'Trading update for the ten months ended 31 October 2024', the firm reported a strong Group organic sales growth of 7.7%, while Smith+Nephew, October 2024, in the 'Third Quarter 2024 Trading Report', noted that revenue for their Advanced Wound Management segment rose by 6.5% on a reported basis, reflecting the heightened global need for sophisticated wound care products.

Simultaneously, the rising global volume of minimally invasive and surgical procedures serves as a vital catalyst for the biomedical textiles industry. As healthcare infrastructure develops in emerging markets and the aging global population necessitates more frequent medical interventions, there is a corresponding increase in the utilization of both implantable textiles, like vascular grafts and hernia meshes, and non-implantable disposables such as surgical gowns and drapes. This upward trend is substantiated by the financial results of leading medical technology companies; according to Medtronic, May 2024, in the 'Fiscal Year 2024 Financial Results', global revenue for the Medical Surgical Portfolio grew by 5.4% due to broad strength in surgical solutions, highlighting the critical function of biocompatible fabrics in maintaining infection control and supporting surgical workflows in busy hospital environments.

Market Challenge

The stringent regulatory framework governing medical devices presents a formidable obstacle to the expansion of the Global Biomedical Textiles Market. Manufacturers are compelled to maneuver through intricate compliance systems, including the FDA standards and the European Medical Device Regulation (MDR), which significantly prolong product approval durations and drive up development expenses. These regulations necessitate exhaustive clinical data and ongoing post-market surveillance, forcing organizations to reallocate substantial capital and human resources from research and development to regulatory affairs, which subsequently decelerates the pace of innovation and delays the introduction of advanced textile-based medical solutions needed for implantable devices and sophisticated wound care.

This operational pressure directly influences global competitiveness and market expansion strategies. Companies are becoming increasingly reluctant to launch new products in regions characterized by burdensome compliance requirements, often favoring markets with more predictable regulatory environments or choosing to discontinue legacy textile products that are no longer profitable to maintain. According to MedTech Europe, in 2024, the proportion of major medical device manufacturers choosing the European Union as their priority geography for initial product launches declined by 33% due to these complexities, demonstrating how compliance hurdles heighten financial risk and actively deter the commercialization of new biomedical textile technologies in critical regions.

Market Trends

The rise of smart textiles equipped with embedded biosensors is revolutionizing the market by transitioning value from passive materials to active, data-generating diagnostic instruments. Unlike conventional garments or dressings, these e-textiles utilize nanotechnology to facilitate continuous remote patient monitoring, enabling the real-time tracking of vital signs like cardiac activity and blood pressure without the need for invasive equipment. This technological convergence supports the wider digital health ecosystem by allowing for personalized care pathways and early intervention; highlighting this progress, according to Nanowear, January 2024, in the 'Nanowear Announces FDA 510(k) Clearance for AI-enabled Continuous Blood Pressure Monitoring and Hypertension Diagnostic Management' press release, the company received approval for its cloth-based wearable platform, signifying a major step in commercializing medical-grade textile sensors.

Concurrently, the industry is experiencing a structural shift toward eco-friendly and sustainable production techniques to reduce the environmental footprint of synthetic fibers and single-use medical disposables. Manufacturers are increasingly replacing petrochemical-based polymers with biodegradable, bio-based, or recycled feedstocks to decrease their carbon emissions while adhering to rigorous biocompatibility standards. This move represents a competitive differentiator as well as a regulatory necessity, prompting operational adjustments throughout the supply chain; according to Ahlstrom, March 2024, in the 'Sustainability Report 2023', the firm realized a 7% decrease in carbon dioxide emissions per ton of production, demonstrating the concrete steps major industry players are taking toward greener manufacturing within the specialty materials sector.

Key Market Players

  • Swicofil AG
  • DSM BV
  • Cortland Biomedical
  • Poly-Med Incorporated
  • Bally Ribbon Mills, Inc.
  • Atex Technologies Inc.
  • Medline Industries Inc.
  • B. Braun Melsungen AG
  • Integra Lifesciences Corporation
  • Elkem ASA

Report Scope

In this report, the Global Biomedical Textiles Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biomedical Textiles Market, By Fibre Type

  • Non-Biodegradable Fibre
  • Biodegradable Fibre

Biomedical Textiles Market, By Fabric Type

  • Non-Woven Fabric
  • Woven Fabric
  • Others

Biomedical Textiles Market, By Application

  • Non-Implantable
  • Surgical Suture
  • Others

Biomedical Textiles Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biomedical Textiles Market.

Available Customizations:

Global Biomedical Textiles Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biomedical Textiles Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Fibre Type (Non-Biodegradable Fibre, Biodegradable Fibre)
    • 5.2.2. By Fabric Type (Non-Woven Fabric, Woven Fabric, Others)
    • 5.2.3. By Application (Non-Implantable, Surgical Suture, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Biomedical Textiles Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Fibre Type
    • 6.2.2. By Fabric Type
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biomedical Textiles Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Fibre Type
        • 6.3.1.2.2. By Fabric Type
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Biomedical Textiles Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Fibre Type
        • 6.3.2.2.2. By Fabric Type
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Biomedical Textiles Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Fibre Type
        • 6.3.3.2.2. By Fabric Type
        • 6.3.3.2.3. By Application

7. Europe Biomedical Textiles Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Fibre Type
    • 7.2.2. By Fabric Type
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biomedical Textiles Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Fibre Type
        • 7.3.1.2.2. By Fabric Type
        • 7.3.1.2.3. By Application
    • 7.3.2. France Biomedical Textiles Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Fibre Type
        • 7.3.2.2.2. By Fabric Type
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Biomedical Textiles Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Fibre Type
        • 7.3.3.2.2. By Fabric Type
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Biomedical Textiles Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Fibre Type
        • 7.3.4.2.2. By Fabric Type
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Biomedical Textiles Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Fibre Type
        • 7.3.5.2.2. By Fabric Type
        • 7.3.5.2.3. By Application

8. Asia Pacific Biomedical Textiles Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Fibre Type
    • 8.2.2. By Fabric Type
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Biomedical Textiles Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Fibre Type
        • 8.3.1.2.2. By Fabric Type
        • 8.3.1.2.3. By Application
    • 8.3.2. India Biomedical Textiles Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Fibre Type
        • 8.3.2.2.2. By Fabric Type
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Biomedical Textiles Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Fibre Type
        • 8.3.3.2.2. By Fabric Type
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Biomedical Textiles Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Fibre Type
        • 8.3.4.2.2. By Fabric Type
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Biomedical Textiles Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Fibre Type
        • 8.3.5.2.2. By Fabric Type
        • 8.3.5.2.3. By Application

9. Middle East & Africa Biomedical Textiles Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Fibre Type
    • 9.2.2. By Fabric Type
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Biomedical Textiles Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Fibre Type
        • 9.3.1.2.2. By Fabric Type
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Biomedical Textiles Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Fibre Type
        • 9.3.2.2.2. By Fabric Type
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Biomedical Textiles Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Fibre Type
        • 9.3.3.2.2. By Fabric Type
        • 9.3.3.2.3. By Application

10. South America Biomedical Textiles Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Fibre Type
    • 10.2.2. By Fabric Type
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biomedical Textiles Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Fibre Type
        • 10.3.1.2.2. By Fabric Type
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Biomedical Textiles Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Fibre Type
        • 10.3.2.2.2. By Fabric Type
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Biomedical Textiles Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Fibre Type
        • 10.3.3.2.2. By Fabric Type
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Biomedical Textiles Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Swicofil AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. DSM BV
  • 15.3. Cortland Biomedical
  • 15.4. Poly-Med Incorporated
  • 15.5. Bally Ribbon Mills, Inc.
  • 15.6. Atex Technologies Inc.
  • 15.7. Medline Industries Inc.
  • 15.8. B. Braun Melsungen AG
  • 15.9. Integra Lifesciences Corporation
  • 15.10. Elkem ASA

16. Strategic Recommendations

17. About Us & Disclaimer